Concepts (96)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bruch Membrane | 2 | 2017 | 2 | 0.900 |
Why?
|
| Photoreceptor Cells, Vertebrate | 2 | 2014 | 33 | 0.720 |
Why?
|
| Macular Degeneration | 2 | 2017 | 30 | 0.610 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 2 | 2016 | 63 | 0.540 |
Why?
|
| Proteoglycans | 1 | 2017 | 49 | 0.530 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2017 | 78 | 0.510 |
Why?
|
| DNA | 1 | 2017 | 594 | 0.430 |
Why?
|
| Mutation | 1 | 2017 | 1169 | 0.370 |
Why?
|
| Retina | 1 | 2014 | 288 | 0.360 |
Why?
|
| Macromolecular Substances | 1 | 2011 | 95 | 0.350 |
Why?
|
| Cell Membrane Permeability | 1 | 2011 | 57 | 0.350 |
Why?
|
| Serum Albumin | 1 | 2011 | 58 | 0.350 |
Why?
|
| Preservation, Biological | 1 | 2009 | 3 | 0.300 |
Why?
|
| Cell Culture Techniques | 1 | 2009 | 151 | 0.280 |
Why?
|
| Light | 1 | 2009 | 182 | 0.280 |
Why?
|
| Potassium Channels, Tandem Pore Domain | 2 | 2015 | 14 | 0.230 |
Why?
|
| Animals | 9 | 2019 | 16695 | 0.160 |
Why?
|
| Reishi | 1 | 2019 | 10 | 0.150 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2019 | 25 | 0.150 |
Why?
|
| Disease Models, Animal | 2 | 2017 | 1554 | 0.150 |
Why?
|
| Glioblastoma | 1 | 2019 | 69 | 0.140 |
Why?
|
| Brain Neoplasms | 1 | 2019 | 129 | 0.140 |
Why?
|
| Biological Products | 1 | 2019 | 91 | 0.140 |
Why?
|
| Mice, Mutant Strains | 1 | 2017 | 85 | 0.130 |
Why?
|
| DNA Mutational Analysis | 1 | 2017 | 97 | 0.130 |
Why?
|
| Peptide Fragments | 1 | 2019 | 301 | 0.130 |
Why?
|
| Carrier Proteins | 1 | 2019 | 318 | 0.130 |
Why?
|
| Mutation, Missense | 1 | 2016 | 88 | 0.120 |
Why?
|
| Membrane Proteins | 1 | 2019 | 548 | 0.120 |
Why?
|
| Cell Movement | 1 | 2019 | 640 | 0.120 |
Why?
|
| Ischemic Attack, Transient | 1 | 2015 | 22 | 0.120 |
Why?
|
| Rats, Long-Evans | 3 | 2009 | 108 | 0.110 |
Why?
|
| Alligators and Crocodiles | 1 | 2014 | 9 | 0.110 |
Why?
|
| Glutamates | 1 | 2014 | 23 | 0.110 |
Why?
|
| Protein Biosynthesis | 1 | 2015 | 136 | 0.110 |
Why?
|
| Ion Channel Gating | 1 | 2014 | 81 | 0.110 |
Why?
|
| Potassium | 1 | 2014 | 109 | 0.100 |
Why?
|
| Membrane Potentials | 1 | 2014 | 221 | 0.100 |
Why?
|
| Fluorescent Dyes | 1 | 2014 | 182 | 0.100 |
Why?
|
| Protein Structure, Tertiary | 1 | 2014 | 427 | 0.100 |
Why?
|
| Astrocytes | 1 | 2015 | 244 | 0.100 |
Why?
|
| Retinal Vessels | 2 | 2009 | 29 | 0.100 |
Why?
|
| Aging | 1 | 2017 | 764 | 0.090 |
Why?
|
| Nerve Tissue Proteins | 1 | 2014 | 382 | 0.090 |
Why?
|
| Chromatography, Gel | 1 | 2011 | 52 | 0.090 |
Why?
|
| Cell Survival | 2 | 2019 | 934 | 0.090 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 860 | 0.090 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2011 | 158 | 0.090 |
Why?
|
| Antineoplastic Agents | 1 | 2019 | 979 | 0.090 |
Why?
|
| Biological Transport | 1 | 2011 | 201 | 0.090 |
Why?
|
| Swine | 1 | 2011 | 205 | 0.080 |
Why?
|
| Rats | 4 | 2016 | 3701 | 0.080 |
Why?
|
| Mice | 2 | 2019 | 6490 | 0.080 |
Why?
|
| Regional Blood Flow | 1 | 2009 | 52 | 0.080 |
Why?
|
| Signal Transduction | 2 | 2019 | 2111 | 0.080 |
Why?
|
| Nitric Oxide Synthase | 1 | 2009 | 134 | 0.070 |
Why?
|
| Ophthalmoscopy | 1 | 2008 | 12 | 0.070 |
Why?
|
| Hyperoxia | 1 | 2008 | 8 | 0.070 |
Why?
|
| Breast Neoplasms | 1 | 2019 | 1679 | 0.070 |
Why?
|
| Time Factors | 2 | 2009 | 1848 | 0.070 |
Why?
|
| Eye | 1 | 2008 | 80 | 0.070 |
Why?
|
| Enzyme Inhibitors | 1 | 2009 | 457 | 0.070 |
Why?
|
| Cell Line, Tumor | 3 | 2019 | 2598 | 0.060 |
Why?
|
| Neurons | 1 | 2014 | 1246 | 0.060 |
Why?
|
| Nitric Oxide | 1 | 2009 | 381 | 0.060 |
Why?
|
| Pseudopodia | 1 | 2019 | 15 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2019 | 62 | 0.040 |
Why?
|
| Blood Flow Velocity | 2 | 2009 | 88 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 1 | 2019 | 284 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2019 | 452 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2019 | 557 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2016 | 135 | 0.030 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2015 | 74 | 0.030 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2015 | 79 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 1804 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2015 | 400 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2015 | 534 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2015 | 1617 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2015 | 1737 | 0.020 |
Why?
|
| Injections | 1 | 2009 | 40 | 0.020 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2009 | 36 | 0.020 |
Why?
|
| Guanidines | 1 | 2009 | 18 | 0.020 |
Why?
|
| Nitro Compounds | 1 | 2009 | 34 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2009 | 57 | 0.020 |
Why?
|
| Imidazoles | 1 | 2009 | 138 | 0.020 |
Why?
|
| Intraocular Pressure | 1 | 2009 | 133 | 0.020 |
Why?
|
| Heart Rate | 1 | 2009 | 261 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 456 | 0.020 |
Why?
|
| Microspheres | 1 | 2008 | 49 | 0.020 |
Why?
|
| Lasers | 1 | 2008 | 57 | 0.020 |
Why?
|
| Hemodynamics | 1 | 2008 | 101 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2008 | 238 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2009 | 662 | 0.010 |
Why?
|
| Humans | 2 | 2019 | 42163 | 0.010 |
Why?
|
| Female | 1 | 2019 | 24018 | 0.010 |
Why?
|
| Male | 2 | 2009 | 22779 | 0.010 |
Why?
|